Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 17414 | 52465;52466;52467 | chr2:178608771;178608770;178608769 | chr2:179473498;179473497;179473496 |
N2AB | 15773 | 47542;47543;47544 | chr2:178608771;178608770;178608769 | chr2:179473498;179473497;179473496 |
N2A | 14846 | 44761;44762;44763 | chr2:178608771;178608770;178608769 | chr2:179473498;179473497;179473496 |
N2B | 8349 | 25270;25271;25272 | chr2:178608771;178608770;178608769 | chr2:179473498;179473497;179473496 |
Novex-1 | 8474 | 25645;25646;25647 | chr2:178608771;178608770;178608769 | chr2:179473498;179473497;179473496 |
Novex-2 | 8541 | 25846;25847;25848 | chr2:178608771;178608770;178608769 | chr2:179473498;179473497;179473496 |
Novex-3 | None | None | chr2:None | chr2:None |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/L | rs2154197858 | None | None | N | 0.155 | 0.248 | 0.395441342475 | gnomAD-3.1.2 | 6.58E-06 | None | None | None | None | N | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 1.47E-05 | 0 | 0 |
P/L | rs2154197858 | None | None | N | 0.155 | 0.248 | 0.395441342475 | gnomAD-4.0.0 | 6.57791E-06 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 1.47275E-05 | 0 | 0 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/A | 0.0682 | likely_benign | 0.0702 | benign | -0.207 | Destabilizing | None | N | 0.153 | neutral | N | 0.40952454 | None | None | N |
P/C | 0.453 | ambiguous | 0.4297 | ambiguous | -0.61 | Destabilizing | 0.667 | D | 0.363 | neutral | None | None | None | None | N |
P/D | 0.2584 | likely_benign | 0.2692 | benign | -0.107 | Destabilizing | 0.22 | N | 0.301 | neutral | None | None | None | None | N |
P/E | 0.1817 | likely_benign | 0.1901 | benign | -0.234 | Destabilizing | 0.055 | N | 0.311 | neutral | None | None | None | None | N |
P/F | 0.4515 | ambiguous | 0.4262 | ambiguous | -0.628 | Destabilizing | 0.22 | N | 0.44 | neutral | None | None | None | None | N |
P/G | 0.2107 | likely_benign | 0.2022 | benign | -0.274 | Destabilizing | 0.055 | N | 0.264 | neutral | None | None | None | None | N |
P/H | 0.1898 | likely_benign | 0.1864 | benign | 0.032 | Stabilizing | 0.602 | D | 0.335 | neutral | N | 0.468303485 | None | None | N |
P/I | 0.212 | likely_benign | 0.2131 | benign | -0.188 | Destabilizing | 0.055 | N | 0.257 | neutral | None | None | None | None | N |
P/K | 0.2196 | likely_benign | 0.2189 | benign | -0.179 | Destabilizing | 0.055 | N | 0.322 | neutral | None | None | None | None | N |
P/L | 0.1103 | likely_benign | 0.1078 | benign | -0.188 | Destabilizing | None | N | 0.155 | neutral | N | 0.42101097 | None | None | N |
P/M | 0.2015 | likely_benign | 0.1971 | benign | -0.311 | Destabilizing | 0.497 | N | 0.365 | neutral | None | None | None | None | N |
P/N | 0.1988 | likely_benign | 0.2051 | benign | 0.048 | Stabilizing | 0.124 | N | 0.305 | neutral | None | None | None | None | N |
P/Q | 0.1346 | likely_benign | 0.1348 | benign | -0.181 | Destabilizing | 0.22 | N | 0.295 | neutral | None | None | None | None | N |
P/R | 0.204 | likely_benign | 0.1946 | benign | 0.247 | Stabilizing | 0.001 | N | 0.199 | neutral | N | 0.432940117 | None | None | N |
P/S | 0.1045 | likely_benign | 0.1051 | benign | -0.277 | Destabilizing | None | N | 0.14 | neutral | N | 0.414487642 | None | None | N |
P/T | 0.0787 | likely_benign | 0.0815 | benign | -0.308 | Destabilizing | 0.042 | N | 0.333 | neutral | N | 0.427590226 | None | None | N |
P/V | 0.1464 | likely_benign | 0.1447 | benign | -0.164 | Destabilizing | 0.002 | N | 0.155 | neutral | None | None | None | None | N |
P/W | 0.5835 | likely_pathogenic | 0.55 | ambiguous | -0.705 | Destabilizing | 0.958 | D | 0.368 | neutral | None | None | None | None | N |
P/Y | 0.39 | ambiguous | 0.3827 | ambiguous | -0.39 | Destabilizing | 0.667 | D | 0.437 | neutral | None | None | None | None | N |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.